| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZD6244 | CCLE | pan-cancer | AAC | 0.19 | 2e-05 |
| mRNA | TKI258 | CCLE | pan-cancer | AAC | 0.19 | 6e-05 |
| mRNA | RAF265 | CCLE | pan-cancer | AAC | 0.18 | 0.0003 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | 0.16 | 0.0003 |
| mRNA | Sorafenib | CCLE | pan-cancer | AAC | 0.16 | 0.0008 |
| mRNA | PLX4720 | CCLE | pan-cancer | AAC | 0.14 | 0.001 |
| mRNA | TAE684 | CCLE | pan-cancer | AAC | 0.077 | 0.1 |
| mRNA | Nilotinib | CCLE | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | L-685458 | CCLE | pan-cancer | AAC | 0.063 | 0.2 |
| mRNA | PD-0332991 | CCLE | pan-cancer | AAC | 0.057 | 0.2 |